Advancing Viral Vector Manufacturing
SK pharmteco (breakthroughmedicines.com) scores 71 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Manufacturing brands, in the 26th percentile of 10334 Healthcare brands.
SK pharmteco is a contract development and manufacturing organization (CDMO) specializing in viral vector production for gene therapies. It provides integrated services for AAV, lentiviral, and adenovirus programs, covering process development, manufacturing, and scale-up. The company operates facilities across North America and Europe and uses its proprietary SKyvec™ platform. Its target customers are biotechnology and pharmaceutical companies developing gene and cell therapies that require viral vector manufacturing support.
| Brand Name | SK pharmteco |
|---|---|
| Domain | breakthroughmedicines.com |
| Industry | Healthcare, Manufacturing |
| Main Competitors | Catalent (81/100), Lonza (86/100), Thermo Fisher Scientific (90/100), WuXi Advanced Therapies, Charles River Laboratories (69/100), Cognate BioServices (part of Charles River), FUJIFILM Diosynth Biotechnologies (74/100), Oxford Biomedica, Batavia Biosciences |
Moz Domain Authority 28/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Integrated viral vector CDMO services for AAV, lentiviral, and adenovirus programs, supporting process development, manufacturing, and scale-up across facilities in North America a…" (Meta description: 24 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost, HubSpot.
Social footprint: verified profiles on YouTube, LinkedIn, Facebook, Instagram; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is SK pharmteco?", Claude could identify the brand as of September 2026. SK pharmteco is a global CDMO (contract development and manufacturing organization) owned by SK Group of South Korea, providing API and biologics manufacturing services with a growing focus on cell and gene therapy production. Best known for Contract manufacturing of pharmaceutical APIs and cell and gene therapies for biotech and pharma clients.
When asked "Best brands similar to SK pharmteco?", Claude would recommend SK pharmteco as of September 2026. It's a legitimate and notable player in the CDMO space, especially in cell and gene therapy manufacturing, so it would be relevant if someone asked about CDMOs similar to Lonza or Catalent.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
SK pharmteco's main competitors in Healthcare: Catalent (81/100), Lonza (86/100), Thermo Fisher Scientific (90/100), Charles River Laboratories (69/100), FUJIFILM Diosynth Biotechnologies (74/100).
Sources: Brand Analyzer scan
SK pharmteco offers viral vector CDMO services, including process development, manufacturing, and scale-up for AAV (adeno-associated virus), lentiviral, and adenovirus-based gene therapy programs. These services are delivered through its proprietary SKyvec™ platform across facilities located in North America and Europe.
Sources: SK pharmteco official site
SK pharmteco is a contract development and manufacturing organization (CDMO) that specializes in viral vector production for gene and cell therapy programs, including AAV, lentiviral, and adenovirus platforms.
Sources: SK pharmteco official site
SK pharmteco has low AI-search visibility, scoring 21/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 33, recommendation 43). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: SK pharmteco official site
SK pharmteco provides integrated viral vector CDMO services, including process development, manufacturing, and scale-up support for AAV, lentiviral, and adenovirus-based gene therapy programs, using its proprietary SKyvec™ platform across facilities in North America and Europe.
Sources: SK pharmteco official site
SK pharmteco scores 43/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: SK pharmteco official site
SK pharmteco is known for its integrated viral vector manufacturing capabilities and its proprietary SKyvec™ platform, which supports gene therapy developers with end-to-end process development and scale-up across facilities in North America and Europe.
Sources: SK pharmteco official site
SK pharmteco can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: SK pharmteco official site
SK pharmteco's services are used by biotechnology and pharmaceutical companies that are developing gene and cell therapies requiring viral vector process development and manufacturing support.
Sources: SK pharmteco official site
SK pharmteco scores 21/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
SK pharmteco has a weak AI-visibility profile at 21/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (43/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 28/100. In a live check, Claude could already identify SK pharmteco from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to SK pharmteco: Bodø kommune (71/100), BLK + GRN (71/100), Brightview Senior Living (71/100), Unobravo (antes Buencoco) (71/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.